NCT01668199View on ClinicalTrials.gov

A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Postoperative Ileus
Interventions
DRUG

TZP-101

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY

NCT01668199 - A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101 | Biotech Hunter | Biotech Hunter